Search results
Results from the WOW.Com Content Network
Shares of vaccine researcher Inovio Pharmaceuticals (INO) are currently trading around the $15 level, and one analyst thinks that's a bargain. Oppenheimer analyst Hartaj Singh makes the argument ...
Inovio's net loss for the third quarter of 2024 was $25.2 million, or $0.89 per share, basic and dilutive, compared to a net loss of $33.9 million, or $1.52 per share, basic and dilutive, for the ...
Yet, the average price target of $26.50 implies 31% upside from current levels. (See Inovio stock-price forecast on TipRanks)To find good ideas for biotech stocks trading at attractive valuations ...
Inovio Pharmaceuticals (NASDAQ:INO) is heating up, as investors continue to flock to certain stocks for the novel coronavirus. Shares of INO stock have rallied 140% from the April 15 low to the ...
Inovio Pharmaceuticals, Inc. is an American biotechnology ... claiming it exaggerated evidence of its coronavirus vaccine's efficacy in order to boost its stock price ...
This week, one of the key players in the COVID-19 vaccine race took a leap forward.On Tuesday, Inovio Pharmaceuticals (INO) announced that Thermo Fisher Scientific had signed a letter of intent to ...
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
Recent times have not been rewarding for investors of vaccine maker Inovio (INO). Over the past two months, shares have declined by a depressing 48%. However, zoom out and a different picture ...